Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

1.52
Delayed Data
As of Apr 01
 0.00 / 0.00%
Today’s Change
0.61
Today|||52-Week Range
2.02
+80.91%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$75.6M

Company Description

AVEO Pharmaceuticals, Inc. is a cancer therapeutics company, which is discovering, developing and commercializing targeted therapies to treat patients with cancer. Its proprietary human response platform provides the company unique insights into cancer and related disease biology and is being leveraged in the discovery and clinical development of its therapeutic candidates. The company's product candidates include AV-203, ficlatuzumab, tivozanib and AV-380. AVEO Pharmaceuticals was founded by Ronald A. DePinho, Lynda Chin and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA.

Contact Information

AVEO Pharmaceuticals, Inc.
650 East Kendall Street
Cambridge Massachusetts 02142
P:(617) 299-5000
Investor Relations:
(617) 299-5810

Employees

Shareholders

Mutual fund holders6.84%
Other institutional19.34%
Individual stakeholders13.14%

Top Executives

Michael P. BaileyPresident, CEO, CFO & Director
Michael N. NeedleChief Medical Officer
Joseph VittiglioSecretary, General Counsel & Senior Vice President
Robert KloppenburgVP-Corporate Communications & Public Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account